Estrogenic effects of marijuana smoke condensate and cannabinoid compounds

Toxicology and Applied Pharmacology

Volumn 214, Issue 3, 2006, Pages 270-278

  Lee, Soo Yeun ^a,b   Oh, Seung Min ^b   Chung, Kyu Hyuck ^b  

^a National Institute of Scientific Investigation   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Cannabinoids; Drug abuse; Estrogen receptor; Estrogenic effects; Marijuana

Indexed keywords

CANNABIDIOL; CANNABINOID; CANNABIS; DRONABINOL; ENDOCRINE DISRUPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BIOASSAY; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; ESTROGEN ACTIVITY; EVALUATION; FEMALE; GAS CHROMATOGRAPHY; GENE EXPRESSION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; POLYMERIZATION; RECEPTOR BINDING; REPORTER GENE; SMOKING; UTERUS;

ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL ASSAY; CANNABINOIDS; CANNABIS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGENS, NON-STEROIDAL; FEMALE; GENES, REPORTER; HUMANS; LUCIFERASES; ORGAN SIZE; RATS; RECEPTORS, ESTROGEN; SMOKE; UTERUS; XENOBIOTICS;

CANNABIS SATIVA;

EID: 33746191771     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.12.019     Document Type: Article

References (42)

1. Arcaro K.F., O'Keefe P.W., Yang Y., Clayton W., and Gierthy J.F. Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 133 (1999) 115-127
2. Ashton C.H. Adverse effects of cannabis and cannabinoids: a review. Br. J. Anaesth. 83 (1999) 637-649
3. Ashton C.H. Pharmacology and effects of cannabis: a brief review. Br. J. Psychiatry 178 (2001) 101-106
4. Berthois Y., Katzenellenbogen J.A., and Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 2496-2500
5. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Branham W.S., Zehr D.R., and Sheehan D.M. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc. Soc. Exp. Biol. Med. 203 (1993) 297-303
7. Brown T.T., and Dobs A.S. Endocrine effects of marijuana: a review. J. Clin. Pharmacol. 42 (2002) 90S-96S
8. Campagnoli C., Abba C., Ambroggio S., and Peri sC. Differential effects of progestins on the circulating IGF-I system. Maturitas 10 (2003) S39-S44
9. Chung H., Park M., Hahn E., Choi H., Choi H., and Lim M. Recent trends of drug abuse and drug-associated deaths in Korea. Ann. N. Y. Acad. Sci. 1025 (2004) 458-464
10. Diel P., Walter A., Fritzemeier K.H., Hegele-Hartung C., and Knauthe R. Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus. J. Steroid Biochem. Mol. Biol. 55 (1995) 363-373
11. Diel P., Schmidt S., and Vollmer G. In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens. J. Chromatogr., B Analyt. Technol. Biomed. Life Sci. 777 (2002) 191-202
12. Furuta C., Suzuki A.K., Taneda S., Kamata K., Hayashi H., Mori Y., Li C., Wang J., Xie P., Kettrup A., and Schramm K.W. Evaluation of soot particles of biomass fuels with endocrine-modulating activity in yeast-based bioassay. Anal. Bioanal. Chem. 381 (2005) 1609-1618
13. Geis R.B., Diel P., Degen G.H., and Vollmer G. Effects of genistein on the expression of hepatic genes in two rat strains (Sprague-Dawley and Wistar). Toxicol. Lett. 157 (2005) 21-29
14. Kabir-Salmani M., Shimizu Y., Sakai K., and Iwashita M. Posttranslational modifications of decidual IGFBP-1 by steroid hormones in vitro. Mol. Hum. Reprod. (2005) (electronic publication ahead of print)
15. Kamiya M., Toriba A., Onoda Y., Kizu R., and Hayakawa K. Evaluation of estrogenic activities of hydroxylated polycyclic aromatic hydrocarbons in cigarette smoke condensate. Food Chem. Toxicol. 43 (2005) 1017-1027
16. Khalsa J.H., Genser S., Francis H., and Martin B. Clinical consequences of marijuana. J. Clin. Pharmacol. 42 (2002) 7S-10S
17. Kinjo J., Tsuchihashi R., Morito K., Hirose T., Aomori T., Nagao T., Okabe H., Nohara T., and Masamune Y. Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol. Pharm. Bull. 27 (2004) 185-188
18. Kojima M., Fukunaga K., Sasaki M., Nakamura M., Tsuji M., and Nishiyama T. Evaluation of estrogenic activities of pesticides using an in vitro reporter gene assay. Int. J. Environ. Health Res. 15 (2005) 271-280
19. Korach K.S., Davis V.L., Curtis S.W., and Bocchinfuso W.P. Xenoestrogens and estrogen receptor action. In: Thomas J.A., and Colby H.D. (Eds). Endocrine Toxicology. 2nd ed. (1997), Taylor and Francis 181-205
20. Lares A., Ochoa Y., Bolanos A., Aponte N., and Montenegro M. Effects of the resin and smoke condensate of Cannabis sativa on the oestrous cycle of the rat. Bull. Narc. 33 (1981) 55-61
21. Lewtas J., Chuang J., Nishioka M., and Peterson B. Bioassay-directed fractionation of the organic extract of SRM 1649 urban air particulate matter. Int. J. Environ. Anal. Chem. 39 (1990) 245-256
22. Martin BR. Cellular effects of cannabinoids. Pharmacol. Rev. 38 (1986) 45-74
23. McCarty M.F. Estrogen agonists/antagonists may down-regulate growth hormone signaling in hepatocytes-an explanation for their impact on IGF-I, IGFBP-1, and lipoprotein(a). Med. Hypotheses 61 (2003) 335-339
24. Nahas G., and Latour C. The human toxicity of marijuana: a review. Med. J. Aust. 156 (1992) 495-497
25. Nikolic R.S., Pavlovic B., Misic Z., and Nikolic G.M. The change of volatile phenols content in cigarette smoke condensate by the addition of metal salts to cigarettes before smoking. Phys. Chem. Technol. 1 (1997) 41-46
26. Nira B.J. Xenoestrogens: prevalence, biologic effects, and mechanism of action. In: Puga A., and Wallace K.B. (Eds). Molecular Biology of the Toxic Response (1999), Talylor and Francis 285-294
27. Nishihara T., Nishikawa J., Kanayama T., Dakeyama F., Saito K., Imagawa Y., Hori S., and Utsumi H. Estrogenic activities of 517 chemicals by yeast two-hybrid assay. J. Health Sci. 46 (2000) 282-298
28. Oh S.M., and Chung K.H. Estrogenic activities of Ginkgo biloba extracts. Life Sci. 74 (2004) 1325-1335
29. Olea N., Pulgar R., Perez P., Olea-Serrano F., Rivas A., Novillo-Fertrell A., Pedraza V., Soto A.M., and Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect. 1043 (1996) 298-305
30. Papaconstantinou A.D., Umbreit T.H., Fisher B.R., Goering P.L., Lappas N.T., and Brown K.M. Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: role of the estrogen receptor. Toxicol. Sci. 56 (2000) 332-339
31. Perez P., Pulgar R., Olea-Serrano F., Villalobos M., Rivas A., Metzler M., Pedraza V., and Olea N. The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ. Health Perspect. 106 (1998) 167-174
32. Rawitch A.B., Schultz G.S., Ebner K.E., and Vardaris R.M. Competition of delta 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding. Science 197 (1977) 1189-1191
33. Robert M.J. A Primer of Drug Action (1988), W.H. Freeman and Company, New York
34. Ruh M.F., Taylor J.A., Howlett A.C., and Welshons W.V. Failure of cannabinoid compounds to stimulate estrogen receptors. Biochem. Pharmacol. 53 (1997) 35-41
35. Sauer M.A., Rifka S.M., Hawks R.L., Cutler Jr. G.B., and Loriaux D.L. Marijuana: interaction with the estrogen receptor. J. Pharmacol. Exp. Ther. 224 (1983) 404-407
36. Smith R.G., Besch N.F., Besch P.K., and Smith C.G. Inhibition of gonadotropin by delta9-tetrahydrocannabinol:mediation by steroid receptors?. Science 204 (1979) 325-327
37. Strohsnitter W.C., Noller K.L., Titus-Ernstoff L., Troisi R., Hatch E.E., Poole C., Glynn R.J., and Hsieh C.C. Breast cancer incidence in women prenatally exposed to maternal cigarette smoke. Epidemiology 16 (2005) 342-345
38. Takamura-Enya T., Ishihara J., Tahara S., Goto S., Totsuka Y., Sugimura T., and Wakabayashi K. Analysis of estrogenic activity of foodstuffs and cigarette smoke condensates using a yeast estrogen screening method. Food Chem. Toxicol. 41 (2003) 543-550
39. Terry P.D., and Rohan T.E. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol., Biomarkers Prev. 11 (2002) 953-971
40. Wang J., Xie P., Kettrup A., and Schramm K.W. Evaluation of soot particles of biomass fuels with endocrine-modulating activity in yeast-based bioassay. Anal. Bioanal. Chem. 381 (2005) 1609-1618
41. Watanabe K., Motoya E., Matsuzawa N., Funahashi T., Kimura T., Matsunaga T., Arizono K., and Yamamoto I. Marijuana extracts possess the effects like the endocrine disrupting chemicals. Toxicology 206 (2005) 471-478
42. Zacharewski T.R., Meek M.D., Clemons J.H., Wu Z.F., Fielden M.R., and Matthews J.B. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol. Sci. 46 (1998) 282-293